Extra Strength Acetaminophen 500mg Tablets Recalled for Discoloration
Contract Pharmacal Corporation is recalling 14,616 bottles of Extra Strength Acetaminophen 500mg tablets due to discoloration appearing as brownish tablets. The affected lot was distributed in Michigan.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is a Class II recall with no reported illnesses or injuries. The hazard—discoloration of tablets—is a cosmetic defect with no explicit health impact documented. Per the rubric, this fits low-risk, precautionary recalls.
Plain-English summary
Contract Pharmacal Corporation is recalling 14,616 bottles of Extra Strength Acetaminophen 500mg tablets (100-count bottles, NDC 0904-6730-60, UPC 309046730606) due to discoloration of the tablets. The affected lot is #368638 with an expiration date of May 2025.
The discolored tablets appear brownish and were distributed in Michigan. The FDA classified this as a Class II recall, indicating a potential for adverse health consequences from use of the product.
Consumers who have purchased this product should stop using it and contact their pharmacy, the place of purchase, or Contract Pharmacal Corporation for instructions on how to return the product or obtain a refund. Patients with questions about this recall should consult their healthcare provider or pharmacist.
The recalled product
- Product
- ACETAMINOPHEN (ACETAMINOPHEN)
- Brand
- ACETAMINOPHEN
- Manufacturer
- Contract Pharmacal Corporation
- Category
- Drug
- Hazard
- Affected units
- 14,616
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot#: 368638
- Exp. 05/2025
UPCs (2)
- 0309046730804
- 309046730606
Distribution
Distributed in 1 state:
Related recalls
Same brand · ACETAMINOPHEN
- ModerateAcetaminophen injection containers recalled after discoloration found in one lot
FDA (Drugs) · 2025-09-03
- SevereFDA Recalls Acetaminophen Injection Due to Labeling Mix-up
FDA (Drugs) · 2024-08-28
- SevereAcetaminophen tablets incorrectly labeled with aspirin drug facts information
FDA (Drugs) · 2024-08-14
- HighAcetaminophen Injection Recalled for Temperature Storage Abuse Nationwide
FDA (Drugs) · 2022-08-24
- ModerateAcetaminophen Oral Suspension Recalled Due to Contaminated Raw Ingredient
FDA (Drugs) · 2021-11-17
Same manufacturer · Contract Pharmacal Corporation
See all →- SevereContract Pharmacal Recalls Leader Extra Strength Acetaminophen Tablets
FDA (Drugs) · 2020-02-19
- ModerateContract Pharmacal Recalls Acetaminophen Tablets Due to Foreign Object Contamination
FDA (Drugs) · 2020-02-19
Same hazard · discoloration
See all →- ModerateShilpa Medicare Recalls Discolored PEMRYDI RTU Injection Vials
FDA (Drugs) · 2026-08-26
- SevereShilpa Medicare Recalls Discolored Pemetrexed Injection Vials
FDA (Drugs) · 2026-08-26
- ModeratePantoprazole Sodium Tablets Recalled for Discoloration Issues
FDA (Drugs) · 2026-04-29
- ModerateTavaborole topical solution recalled from three lots because of discoloration
FDA (Drugs) · 2025-10-22
- ModerateTavaborole topical solution recalled after discoloration found in one lot
FDA (Drugs) · 2025-08-27